Technology | November 09, 2012

FDA Clears Relay Thoracic Stent Graft

November 9, 2012 — The U.S. Food and Drug Administration (FDA) recently cleared Bolton Medical’s Relay Thoracic Stent Graft with Plus Delivery System.

The Relay is an endovascular stent graft used to repair fusiform aneurysms or saccular aneurysms/penetrating ulcers of the aorta in the chest. The stent graft is made of a fabric tube supported by a metal framework. Each endovascular stent graft is compressed into the end of a long, thin, delivery catheter.

A fusiform aneurysm is a type of thoracic aortic aneurysm that has a varying diameter and length and typically involves all sides of the diseased vessel. A saccular aneurysm is a type of aneurysm that is circular in shape and typically involves only one side of the diseased vessel. Saccular aneurysms are often associated with penetrating ulcers. A penetrating ulcer is a weak area of the aorta that causes one side of the diseased vessel to bulge or expand. Unlike a saccular aneurysm, a penetrating ulcer does not go completely through the first layer of the aorta.

The delivery catheter containing the endovascular stent graft is inserted into an artery in the groin through a small incision in the skin. It is carefully guided within the artery into the chest to bridge the site of the aneurysm or penetrating ulcer in the aorta. The endovascular stent graft is then released (deployed) in the aorta where it self-expands to the diameter of the aorta to seal off the aneurysm or penetrating ulcer and relines the artery wall.

The Relay Thoracic Stent Graft with Plus Delivery System can be used in place of invasive open surgery in patients who have a fusiform aneurysm or saccular aneurysm/penetrating ulcer of the aorta in the chest.

For more information: www.boltonmedical.com

Related Content

Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases.
News | Endovascular Aortic Repair | May 12, 2021
May 12, 2021 — Preliminary results of a clinical trial, presented today at the ...
Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts
News | Endovascular Aortic Repair | February 23, 2021
February 23, 2021 — Medtronic has voluntarily issued a global recall of unused...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Endovascular Aortic Repair | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...
The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch.  #VIVA19 #VIVA2019

The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. 

News | Endovascular Aortic Repair | November 11, 2019
November 7, 2019 — The Endospan Ltd.
Obese Patients Have More Post-Op Problems Following AAA Repair
News | Endovascular Aortic Repair | November 21, 2018
New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in...
FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
News | Endovascular Aortic Repair | October 08, 2018
Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall...
The Gore TAG stent graft used in TEVAR aortic repair procedures for aneurysms.

The Gore TAG stent graft used for endovascular aortic aneurysm repair procedures.

Feature | Endovascular Aortic Repair | February 05, 2018 | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.
Here are several considerations for physicians when choosing...
Endologix Receives IDE Approval for EVAS2 Confirmatory Clinical Study
News | Endovascular Aortic Repair | October 19, 2017
Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair | May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...